
CPHI Milan 2026
10/2026 – 10/2026
Changchun BCHT Biotechnology is an innovative biopharmaceutical enterprise dedicated to the prevention and treatment of infectious diseases, specializing since its establishment in 2004 in the R&D, production and sales of human vaccines. The company operates its own vaccine manufacturing base covering 225,700 square meters and has built a stable business model with strong market recognition based on core technology R&D and industrialization, going public on the Science and Technology Innovation Board in 2021.

No comments available.
Leave your rating & comment